Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@HemostemixInc](/creator/twitter/HemostemixInc)
"🚨 Milestone: Hemostemix $HEM 📷 $HMTXF $2VF0 files FDA Pre-IND 1517 for ACP-01 (VesCell) basket protocol. One trial. Multiple billion-$ markets: PAD CLI angina CHF vascular dementia. 📖 Read more: #FDA #StemCells"  
[X Link](https://x.com/HemostemixInc/status/1970820513929810407) [@HemostemixInc](/creator/x/HemostemixInc) 2025-09-24T12:00Z XXX followers, XXX engagements


"🚨 New Milestone: $HEM $HMTXF $2VF0 Hemostemix adds Refractory Angina to its Phase X basket trial of ACP-01. Targeting patients with daily chest pain & no remaining treatment options. Read more: 🔗 #Biotech #Cardiology #ClinicalTrials"  
[X Link](https://x.com/HemostemixInc/status/1978800263843479804) [@HemostemixInc](/creator/x/HemostemixInc) 2025-10-16T12:28Z XXX followers, XXX engagements


"What if memory loss starts in your blood vessels 🧠 In vascular dementia reduced blood flow may damage brain tissue linking heart & brain health more closely than ever. Learn how Hemostemix is advancing patient-led stem cell research: 🔗 $HEM $HMTXF $2VF0 #VascularDementia #StemCellResearch #Biotech"  
[X Link](https://x.com/HemostemixInc/status/1978509409065070637) [@HemostemixInc](/creator/x/HemostemixInc) 2025-10-15T17:12Z XXX followers, XXX engagements


"5% of adults over XX live with daily chest pain and no cure. Hemostemixs new Phase X trial targets refractory angina using ACP-01 a patients own cells to help restore blood flow & repair heart tissue. Learn more: #Hemostemix $HEM $HMTXF $2VF0"  
[X Link](https://x.com/HemostemixInc/status/1979155441029648806) [@HemostemixInc](/creator/x/HemostemixInc) 2025-10-17T12:00Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@HemostemixInc "🚨 Milestone: Hemostemix $HEM 📷 $HMTXF $2VF0 files FDA Pre-IND 1517 for ACP-01 (VesCell) basket protocol. One trial. Multiple billion-$ markets: PAD CLI angina CHF vascular dementia. 📖 Read more: #FDA #StemCells"
X Link @HemostemixInc 2025-09-24T12:00Z XXX followers, XXX engagements

"🚨 New Milestone: $HEM $HMTXF $2VF0 Hemostemix adds Refractory Angina to its Phase X basket trial of ACP-01. Targeting patients with daily chest pain & no remaining treatment options. Read more: 🔗 #Biotech #Cardiology #ClinicalTrials"
X Link @HemostemixInc 2025-10-16T12:28Z XXX followers, XXX engagements

"What if memory loss starts in your blood vessels 🧠 In vascular dementia reduced blood flow may damage brain tissue linking heart & brain health more closely than ever. Learn how Hemostemix is advancing patient-led stem cell research: 🔗 $HEM $HMTXF $2VF0 #VascularDementia #StemCellResearch #Biotech"
X Link @HemostemixInc 2025-10-15T17:12Z XXX followers, XXX engagements

"5% of adults over XX live with daily chest pain and no cure. Hemostemixs new Phase X trial targets refractory angina using ACP-01 a patients own cells to help restore blood flow & repair heart tissue. Learn more: #Hemostemix $HEM $HMTXF $2VF0"
X Link @HemostemixInc 2025-10-17T12:00Z XXX followers, XXX engagements

creator/twitter::22017380/posts
/creator/twitter::22017380/posts